EIF5 antibody

Cat.#: 110266

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    EIF5 antibody
  • Documents
  • Description
    EIF5 Rabbit Polyclonal antibody. Positive WB detected in CHO cells. Positive IHC detected in human pancreas cancer tissue. Observed molecular weight by Western-blot: 50 kDa
  • Tested applications
    ELISA, IHC, WB
  • Species reactivity
    Human,Mouse,Rat; other species not tested.
  • Alternative names
    eIF 5 antibody; EIF 5A antibody; EIF5 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained by immunization of EIF5 recombinant protein (Accession Number: NM_183004). Purification method: Antigen affinity purified.
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: N/AIHC: 1:20-1:200

  • Validations

    WB result of EIF5 antibody (Catalog No:110266, 1:500) with CHO cell lysate by Dr. Emma Hargreaves.

    WB result of EIF5 antibody (Catalog No:110266, 1:500) with CHO cell lysate by Dr. Emma Hargreaves.

    Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:110266(EIF5 antibody) at dilution of 1:50 (under 10x lens)

    Immunohistochemical of paraffin-embedded human pancreas cancer using Catalog No:110266(EIF5 antibody) at dilution of 1:50 (under 10x lens)

  • Background
    Eukaryotic translation initiation factor 5, also named as EIF5, is a 431 amino acid protein, which contains one W2 domain and belongs to the eIF-2-beta/eIF-5 family. EIF5 catalyzes the hydrolysis of GTP bound to the 40S ribosomal initiation complex with the subsequent joining of a 60S ribosomal subunit resulting in the release of eIF-2 and the guanine nucleotide. EIF5 plays multiple roles in translation initiation.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"